ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 204 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,483,000 | -51.6% | 46,463 | +2.3% | 0.01% | -52.9% |
| Q4 2015 | $5,132,000 | +2.6% | 45,428 | +6.9% | 0.02% | 0.0% |
| Q3 2015 | $5,004,000 | +62.0% | 42,513 | +6.6% | 0.02% | +70.0% |
| Q2 2015 | $3,089,000 | +25.8% | 39,892 | -6.1% | 0.01% | +42.9% |
| Q1 2015 | $2,456,000 | +98.2% | 42,462 | +10.5% | 0.01% | +75.0% |
| Q4 2014 | $1,239,000 | +39.7% | 38,412 | +6.0% | 0.00% | +33.3% |
| Q3 2014 | $887,000 | +35.4% | 36,237 | -1.9% | 0.00% | +50.0% |
| Q2 2014 | $655,000 | +47.2% | 36,937 | +66.1% | 0.00% | +100.0% |
| Q1 2014 | $445,000 | +13.2% | 22,234 | -5.1% | 0.00% | 0.0% |
| Q4 2013 | $393,000 | +59.8% | 23,434 | +1.3% | 0.00% | 0.0% |
| Q3 2013 | $246,000 | +87.8% | 23,134 | -1.0% | 0.00% | – |
| Q2 2013 | $131,000 | – | 23,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |